Carbosilane dendrimer and aggregatable carrier obtained using said dendrimer for drug delivery system
The object of the present invention is to provide an aggregatable carrier material for drug delivery system and a micelle formed thereof. The present invention provides an aggregatable carrier material for drug delivery system, which is formed by utilizing the reaction between thiol group and alkyl halide. It is formed by using carbosilane dendrimers containing silole and labeled proteins such as green fluorescent protein in aqueous solvent or in mixed solvent of the aqueous solvent and organic solvent. The micelle composed of the material may incorporate compounds having a variety of molecular weight and biopolymers in the aqueous solvent.
1. An aggregatable carrier material for a drug delivery system comprising an aggregatable dendrimer compound shown in formula (I):
[Chemical formula 1]
R 1 [(R 2 —Si)(—R 3 —Y) 3 ] 2 (I)
wherein in the formula (I), R 1 is silole group shown in the following formula (II); each of R 2 and R 3 is a hydrocarbon chain having 1 to 6 carbon atoms which may have the same or a different hydrocarbon chain or a ring; Y is a halogen group or a targeted sequence presented part (TSPP) bound via a sulfur atom wherein at least one of Y is a TSPP; and
wherein R is a phenyl group; and n is 4 in the formula (II);
wherein the targeted sequence presented part (TSPP) comprises a protein having a targeted recognition site of which said sulfur atom in said protein is located outside the folded protein; and
wherein said targeted sequence presented part aggregates in an aqueous solvent to form a micelle having the diameter from 50 to 500 nm, and when said aggregatable molecule aggregates, said aggregated micelles emit fluorescence.
2. The aggregatable carrier material for a drug delivery system according to claim 1 , wherein said compound shown in formula (I) is that shown in the following formula (III), and wherein n is an integer from 1 to 3, X is a bromine atom or —S-TSPP, and all X are not bromine atoms;
3. The aggregatable carrier material for drug delivery system according to claim 1 , wherein said aggregatable molecule shown in the formula (I) is selected from the group consisting of the following formulae (IV) to (IX);
wherein TSPP is the targeted sequence presented part in the formulae.
4. The aggregatable carrier material for drug delivery system according to claim 1 , wherein the protein having said targeted recognition site is any one of fluorescent proteins selected from the group consisting of a white fluorescent protein, a red fluorescent protein, a yellow fluorescent protein, a blue fluorescent protein and a green fluorescent protein.
5. The aggregatable carrier material for drug delivery system according to claim 1 , wherein said targeted recognition site is a functional peptide to deliver said micelle formed by said aggregatable carrier material to a targeted tissue.
6. The aggregatable carrier material for drug delivery system according to claim 5 , wherein said targeted tissue is any one of a tissue selected from the group consisting of a normal tissue having inflammation, a tissue having undesirable gene expressions, a cell having the undesirable gene expressions, and a tissue composed of premalignant cells and tumor cells.
7. The aggregatable carrier material for drug delivery system according to claim 5 , wherein said functional peptide specifically binds to any targeted protein selected from the group consisting of a surface antigen, a receptor, a gate, a transporter and a channel to form a conjugate for promoting endocytosis of said conjugate composed of said protein and said functional peptide into a cell.
8. A micelle formed by said aggregatable carrier material for drug delivery system according to claim 1 , which encapsulates any one of the molecules selected from the group consisting of a protein having molecular weight of 200,000 or less, a nucleic acid and hydrophobic molecule.
9. The micelle according to claim 8 , wherein said protein having the molecular weight of 200,000 or less is selected from the group consisting of immunoglobulin G, lectins, and peptide hormones.